T: 07376 251249

E: info@taect.scot

© 2018 The Ann Edgar Charitable Trust

Registered Charity No. SCO42556

  • Grey Facebook Icon
  • Grey Twitter Icon

Contact Form

Everolimus (Afinitor) approved for use in Scotland for Net Cancer Patients

13 Feb 2017

The Scottish Medicines Consortium decision regarding Everolimus (Afinitor) was announced this afternoon. The relevant Detailed Advice Document can be found here.

Thank you to all who took part in the survey and the focus group.   You can read our submission here.

Please reload